MINNEAPOLIS & NEW ORLEANS--(BUSINESS WIRE)--The millions of people who cannot control their high blood pressure (hypertension) with drug therapy may have a new option in the future – an implantable device. The Rheos™ Baroreflex Hypertension Therapy™ System, developed by Minneapolis-based CVRx, Inc., is the first implantable device designed to control hypertension, a leading cause of heart and kidney disease, stroke and death.
